Biosion, Inc.

博奥信生物

Biosion, Inc.

Biotech/Healthcare

Biosion is a globally oriented, clinical-stage biotechnology company developing next-generation innovative antibody therapeutics for unmet medical needs worldwide, with a focus on drug resistance, relapse, and residual disease. It advances its pipeline through both in-house innovation and…

Latest round: Series C (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-08-01